Midazolam hydrochloride is commonly used for dental or endoscopic procedures. Although generally considered safe when given intramuscularly, intravenous administration is known to cause respiratory and cardiovascular depression. This report describes the first published case of cardiorespiratory arrest and death associated with intramuscular administration of midazolam. Information regarding midazolam use is reviewed to provide recommendations for safe administration.
Get full access to this article
View all access options for this article.
References
1.
AvramMJFragenRJCaldwellNJ. Dose-finding and pharmacokinetic study of intramuscular midazolam. J Clin Pharmacol1987; 27: 314–7.
2.
GiovannittiJAJr. Midazolam: Review of a versatile agent for use in dentistry. Anesth Prog1987; 34: 164–70.
3.
BirchBMillerR. Safety of midazolam (letter). Lancet1988; 2: 683.
KhanderiaUPanditSK. Use of midazolam hydrochloride in anesthesia. Clin Pharm1987; 6: 533–47.
10.
VandermeerchEVan AkenH. A comparative study between midazolam and thiopental alone or with analgesic and neuroleptic as intravenous induction agents in general anesthesia. Acta Anaesth Belg1987; 38 (suppl 1):23–32.
BerggrenLErikssonIMollenholtP. Changes in breathing pattern and chest wall mechanics after benzodiazepines in combination with meperidine. Acta Anaesthesiol Scand1987; 31: 381–6.
13.
BellGDMordenACoadyTLeeJLoganRFA. A comparison of diazepam and midazolam as endoscopy premedication assessing changes in ventilation and oxygen saturation. Br J Clin Pharmacol1988; 26: 595–600.
14.
AlexanderCMGrossJB. Sedative doses of midazolam depress hypoxic ventilatory responses in humans. Anesth Analg1988; 67: 377–82.
